Pandion Therapeutics to Present at the Stifel 2020 Virtual Healthcare Conference
10 Novembre 2020 - 2:00PM
Pandion Therapeutics, Inc. (Nasdaq: PAND), a clinical-stage
biotechnology company developing novel therapeutics designed to
address the unmet needs of patients living with autoimmune
diseases, today announced that Rahul Kakkar, M.D., Chief Executive
Officer of Pandion Therapeutics, will present at the upcoming
Stifel 2020 Virtual Healthcare Conference on Tuesday, November 17,
2020 at 4:00 p.m. ET.
A live audio webcast of the presentation will be available in
the Investors and News section of Pandion Therapeutics’ website at
https://www.pandiontx.com/. A replay of the webcast will be
available shortly following the presentation.
About Pandion TherapeuticsPandion
Therapeutics is developing novel therapeutics designed to
address the unmet needs of patients living with autoimmune
diseases. Pandion’s TALON (Therapeutic Autoimmune reguLatOry
proteiN) drug design and discovery platform enables the company to
create a pipeline of product candidates using immunomodulatory
effector modules, with the ability to also combine an effector
module with a tissue-targeted tether module in a bifunctional
format. Pandion’s lead product candidate PT101, a combination
of an interleukin-2 mutein effector module with a protein backbone,
is designed to selectively expand regulatory T cells systemically,
without activating proinflammatory cells, such as conventional T
cells and natural killer cells, is currently in a Phase 1a clinical
trial. Pandion is continuing to develop and expand its library of
effector and tether modules as part of its earlier-stage research
and discovery pipeline. For more information, please
visit www.pandiontx.com.
For further information, please contact:
Media:Kathryn MorrisThe Yates
Network914-204-6412kathryn@theyatesnetwork.com
Investors:Michelle AveryPandion
Therapeutics857-273-0444investors@pandiontx.com
Grafico Azioni Pandion Therapeutics (NASDAQ:PAND)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Pandion Therapeutics (NASDAQ:PAND)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a Pandion Therapeutics Inc (NASDAQ): 0 articoli recenti
Più Articoli Notizie